• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型糖尿病患者的血糖变异性:与体重、身体成分和胰岛素敏感性的关联。

Glucose Variability in People with Type 1 Diabetes: Associations with Body Weight, Body Composition, and Insulin Sensitivity.

作者信息

Semenova Julia F, Yushin Anton Yu, Korbut Anton I, Klimontov Vadim V

机构信息

Laboratory of Endocrinology, Research Institute of Clinical and Experimental Lymphology-Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (RICEL-Branch of IC&G SB RAS), 630060 Novosibirsk, Russia.

出版信息

Biomedicines. 2024 Sep 3;12(9):2006. doi: 10.3390/biomedicines12092006.

DOI:10.3390/biomedicines12092006
PMID:39335526
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11428493/
Abstract

The prevalence of overweight and obesity increases in people with type 1 diabetes (T1D). However, the impact of fat accumulation on glucose dynamics in T1D is poorly understood. We assessed continuous glucose monitoring (CGM) parameters in patients with T1D depending on their body weight, body composition, and insulin sensitivity. In 547 patients, including 238 overweight/obese individuals, CGM-derived time in range (TIR) and glucose variability (GV) were estimated. Body composition was assessed by DXA. Estimated glucose disposal rate (eGDR) was used as an indicator of insulin sensitivity. Overweight/obese patients, when compared to normal-weight ones, have a lower time below range (TBR) (<3 mmol/L), GV, and experienced fewer episodes of low glucose. In men, lower TIR, higher time above range (TAR), and GV reduction were associated with central adiposity assessed by total, trunk, and android fat mass. In women, gynoid fat mass only was associated with a lower TIR and higher TAR. The eGDR was a positive predictor of TIR and a negative predictor of TAR, TBR, and GV in men and women. In conclusion, adiposity in people with T1D is associated with a lower risk of CGM-confirmed hypoglycemia, higher TAR, and reduced GV. These features of daily glucose dynamics may be mediated by insulin resistance.

摘要

1型糖尿病(T1D)患者中超重和肥胖的患病率呈上升趋势。然而,脂肪堆积对T1D患者血糖动态变化的影响目前仍知之甚少。我们根据T1D患者的体重、身体成分和胰岛素敏感性评估了其连续血糖监测(CGM)参数。在547例患者中,包括238例超重/肥胖个体,估算了CGM得出的血糖达标时间(TIR)和血糖变异性(GV)。通过双能X线吸收法(DXA)评估身体成分。使用估算的葡萄糖处置率(eGDR)作为胰岛素敏感性的指标。与体重正常的患者相比,超重/肥胖患者血糖低于范围的时间(TBR,<3 mmol/L)、GV较低,且低血糖发作次数较少。在男性中,较低的TIR、较高的血糖高于范围的时间(TAR)以及GV降低与通过总体、躯干和男性型脂肪量评估的中心性肥胖有关。在女性中,仅臀部脂肪量与较低的TIR和较高的TAR有关。eGDR是男性和女性TIR的正向预测因子,以及TAR、TBR和GV的负向预测因子。总之,T1D患者的肥胖与CGM确认的低血糖风险较低、TAR较高和GV降低有关。日常血糖动态变化的这些特征可能由胰岛素抵抗介导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d118/11428493/68a9927b4b2d/biomedicines-12-02006-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d118/11428493/68a9927b4b2d/biomedicines-12-02006-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d118/11428493/68a9927b4b2d/biomedicines-12-02006-g001.jpg

相似文献

1
Glucose Variability in People with Type 1 Diabetes: Associations with Body Weight, Body Composition, and Insulin Sensitivity.1型糖尿病患者的血糖变异性:与体重、身体成分和胰岛素敏感性的关联。
Biomedicines. 2024 Sep 3;12(9):2006. doi: 10.3390/biomedicines12092006.
2
Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?真实世界环境中预混胰岛素类似物治疗 2 型糖尿病患者的血糖:是否达到了 CGM 目标?
Eur J Med Res. 2023 Mar 7;28(1):111. doi: 10.1186/s40001-023-01081-y.
3
Glucose variability in subjects with normal glucose tolerance: Relations with body composition, insulin secretion and sensitivity.糖耐量正常受试者的血糖变异性:与身体成分、胰岛素分泌及敏感性的关系。
Diabetes Metab Syndr. 2022 Jan;16(1):102387. doi: 10.1016/j.dsx.2022.102387. Epub 2022 Jan 5.
4
Continuous Glucose Monitoring in Patients Following Simultaneous Pancreas-Kidney Transplantation: Time in Range and Glucose Variability.胰肾联合移植患者的连续血糖监测:血糖达标时间及血糖变异性
Diagnostics (Basel). 2023 Apr 30;13(9):1606. doi: 10.3390/diagnostics13091606.
5
Insulin Resistance and CGM-Derived Parameters in People With Type 1 Diabetes: Are They Associated?1 型糖尿病患者的胰岛素抵抗与 CGM 衍生参数:它们有关联吗?
J Clin Endocrinol Metab. 2024 Oct 15;109(11):e2131-e2140. doi: 10.1210/clinem/dgae015.
6
Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.使用连续血糖监测系统研究血糖控制良好的 2 型糖尿病患者的血糖变异性。
J Assoc Physicians India. 2024 Jan;72(1):18-21. doi: 10.59556/japi.71.0441.
7
Efficacy of Semaglutide in Overweight and Obese Patients with Type 1 Diabetes.司美格鲁肽在超重和肥胖 1 型糖尿病患者中的疗效。
Diabetes Technol Ther. 2024 Mar;26(3):184-189. doi: 10.1089/dia.2023.0490.
8
Continuous Glucose Monitoring-Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4.基于连续血糖监测的指标及低血糖持续时间:在长期 2 型糖尿病患者中,从每日基础胰岛素转换为每周一次胰岛素伊克塞的疗效:ONWARDS 2 和 ONWARDS 4 的事后分析。
Diabetes Care. 2024 Apr 1;47(4):729-738. doi: 10.2337/dc23-2136.
9
Hypoglycemia and glycemic variability of people with type 1 diabetes with lower and higher physical activity loads in free-living conditions using continuous subcutaneous insulin infusion with predictive low-glucose suspend system.在自由生活条件下,使用具有预测性低血糖暂停系统的持续皮下胰岛素输注,对身体活动负荷较低和较高的1型糖尿病患者的低血糖和血糖变异性进行研究。
BMJ Open Diabetes Res Care. 2023 Mar;11(2). doi: 10.1136/bmjdrc-2022-003082.
10
Association of Body Fat Percentage with Time in Range Generated by Continuous Glucose Monitoring during Continuous Subcutaneous Insulin Infusion Therapy in Type 2 Diabetes.2 型糖尿病患者持续皮下胰岛素输注治疗期间连续血糖监测的时间范围内体脂百分比与时间的相关性。
J Diabetes Res. 2021 May 28;2021:5551216. doi: 10.1155/2021/5551216. eCollection 2021.

引用本文的文献

1
Metabolic syndrome in type 1 diabetes: higher time above range and glycemic variability revealed by continuous glucose monitoring (CGM).1型糖尿病中的代谢综合征:连续血糖监测(CGM)揭示的血糖高于目标范围时间延长及血糖变异性增加
Diabetol Metab Syndr. 2025 Feb 8;17(1):49. doi: 10.1186/s13098-025-01602-1.
2
Are standardized conditions needed for correct CGM data interpretation in subjects at early stages of glucose intolerance?在葡萄糖不耐受早期阶段的受试者中,正确解读动态血糖监测(CGM)数据是否需要标准化条件?
Diabetol Metab Syndr. 2025 Jan 22;17(1):29. doi: 10.1186/s13098-025-01579-x.

本文引用的文献

1
Association of Insulin Resistance With Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: Systematic Review and Meta-analysis.胰岛素抵抗与 1 型糖尿病患者心血管疾病和全因死亡率的相关性:系统评价和荟萃分析。
Diabetes Care. 2024 Dec 1;47(12):2266-2274. doi: 10.2337/dc24-0475.
2
Non-alcoholic fatty liver disease: pathogenesis and models.非酒精性脂肪性肝病:发病机制与模型
Am J Transl Res. 2024 Feb 15;16(2):387-399. doi: 10.62347/KMSA5983. eCollection 2024.
3
Glycemic variability assessed using continuous glucose monitoring in individuals without diabetes and associations with cardiometabolic risk markers: A systematic review and meta-analysis.
使用连续血糖监测评估无糖尿病个体的血糖变异性及其与心血管代谢风险标志物的相关性:系统评价和荟萃分析。
Clin Nutr. 2024 Apr;43(4):915-925. doi: 10.1016/j.clnu.2024.02.014. Epub 2024 Feb 22.
4
Double diabetes-when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition.双重糖尿病——当 1 型糖尿病遇见 2 型糖尿病:定义、发病机制与识别。
Cardiovasc Diabetol. 2024 Feb 10;23(1):62. doi: 10.1186/s12933-024-02145-x.
5
Body composition and metabolic syndrome in patients with type 1 diabetes.1型糖尿病患者的身体成分与代谢综合征
World J Diabetes. 2024 Jan 15;15(1):81-91. doi: 10.4239/wjd.v15.i1.81.
6
Insulin Resistance and CGM-Derived Parameters in People With Type 1 Diabetes: Are They Associated?1 型糖尿病患者的胰岛素抵抗与 CGM 衍生参数:它们有关联吗?
J Clin Endocrinol Metab. 2024 Oct 15;109(11):e2131-e2140. doi: 10.1210/clinem/dgae015.
7
The Impact of Body Mass Index, Residual Beta Cell Function and Estimated Glucose Disposal Rate on the Development of Double Diabetes and Microvascular Complications in Patients With Type 1 Diabetes Mellitus.体重指数、残余β细胞功能及估计的葡萄糖处置率对1型糖尿病患者双糖尿病及微血管并发症发生发展的影响
Cureus. 2023 Nov 17;15(11):e48979. doi: 10.7759/cureus.48979. eCollection 2023 Nov.
8
Glycemic Variability and Time in Range Are Associated with the Risk of Overweight and High LDL-Cholesterol in Children and Youths with Type 1 Diabetes.血糖变异性和血糖达标时间与1型糖尿病儿童及青少年超重和高LDL-胆固醇风险相关。
Horm Res Paediatr. 2025;98(1):59-65. doi: 10.1159/000535554. Epub 2023 Dec 15.
9
The emergence of obesity in type 1 diabetes.1 型糖尿病患者中肥胖症的出现。
Int J Obes (Lond). 2024 Mar;48(3):289-301. doi: 10.1038/s41366-023-01429-8. Epub 2023 Dec 14.
10
Serum Cytokines and Growth Factors in Subjects with Type 1 Diabetes: Associations with Time in Ranges and Glucose Variability.1型糖尿病患者的血清细胞因子和生长因子:与血糖达标时间及血糖变异性的关联
Biomedicines. 2023 Oct 19;11(10):2843. doi: 10.3390/biomedicines11102843.